HDL-AuNPs-BMS nanoparticle conjugates as molecularly targeted therapy for leukemia
N. Shen, F. Yan, J. Pang, Z. Gao, A. Al-Kali, C. L. Haynes, M. R. Litzow, S. Liu
This paper develops HDL-AuNPs-BMS conjugates for leukemia treatment, showing enhanced drug delivery and epigenetic modulation in AML cells and mice.
bioRxiv · Jan 20, 2018Cancer Biology